Social Security Institution adds two new drugs to reimbursement list
Two drugs used in the treatment of early-stage breast cancer and a rare eye disease have been included in the reimbursement scope through a regulation by the Social Security Institution Health Implementation Communique.
The amendment to the Social Security Institution Health Implementation Communique has entered into force after being published in the Official Gazette. With the new regulation, a drug for early-stage breast cancer and a drug used in the treatment of a rare eye disease have been added to the reimbursement list.
New Regulation Published in the Official Gazette
The Communique on Amending the Social Security Institution Health Implementation Communique has entered into force upon publication in the Official Gazette.
Statements by Minister Vedat Işıkhan
Minister of Labor and Social Security Vedat Işıkhan stated in a social media post that they continue to work for citizens with an understanding of effective, sustainable, and accessible healthcare services.
Treatments Included in Reimbursement
In addition to high-tech surgical procedures performed for newborn and pediatric patients, one drug to be used in the treatment of early-stage breast cancer and one drug used in the treatment of a rare disease characterized by optic nerve involvement have been included in the reimbursement scope.
Regulations for Organ Transplantation
It was stated that important regulations have also been implemented to ensure the uninterrupted continuation of organ preservation protocols, which are of vital importance for patients waiting for organ transplants.